RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
SciVision Biotech Stock

SciVision Biotech Equity 2024

SciVision Biotech Equity

1.63 B TWD

Ticker

1786.TW

ISIN

TW0001786002

In 2024, SciVision Biotech's equity was 1.63 B TWD, a 7.65% increase from the 1.51 B TWD equity in the previous year.

SciVision Biotech Aktienanalyse

What does SciVision Biotech do?

SciVision Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing SciVision Biotech's Equity

SciVision Biotech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding SciVision Biotech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating SciVision Biotech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

SciVision Biotech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in SciVision Biotech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about SciVision Biotech stock

What is the equity of SciVision Biotech this year?

SciVision Biotech has equity of 1.63 B TWD this year.

What was the equity of SciVision Biotech compared to the previous year?

The equity of SciVision Biotech has increased/decreased by 7.65% increased compared to the previous year.

What impact does a high equity have on investors of SciVision Biotech?

A high equity is advantageous for investors of SciVision Biotech as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of SciVision Biotech?

A low equity can be a risk for investors of SciVision Biotech, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of SciVision Biotech affect the company?

An increase in equity of SciVision Biotech can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of SciVision Biotech affect the company?

A reduction in equity of SciVision Biotech can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of SciVision Biotech?

Some factors that can affect the equity of SciVision Biotech include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of SciVision Biotech so important for investors?

The equity of SciVision Biotech is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can SciVision Biotech take to change the equity?

To change equity, SciVision Biotech can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does SciVision Biotech pay?

Over the past 12 months, SciVision Biotech paid a dividend of 1.98 TWD . This corresponds to a dividend yield of about 1.54 %. For the coming 12 months, SciVision Biotech is expected to pay a dividend of 2.04 TWD.

What is the dividend yield of SciVision Biotech?

The current dividend yield of SciVision Biotech is 1.54 %.

When does SciVision Biotech pay dividends?

SciVision Biotech pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of SciVision Biotech?

SciVision Biotech paid dividends every year for the past 8 years.

What is the dividend of SciVision Biotech?

For the upcoming 12 months, dividends amounting to 2.04 TWD are expected. This corresponds to a dividend yield of 1.58 %.

In which sector is SciVision Biotech located?

SciVision Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von SciVision Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SciVision Biotech from 8/16/2024 amounting to 2.408 TWD, you needed to have the stock in your portfolio before the ex-date on 7/26/2024.

When did SciVision Biotech pay the last dividend?

The last dividend was paid out on 8/16/2024.

What was the dividend of SciVision Biotech in the year 2023?

In the year 2023, SciVision Biotech distributed 1.418 TWD as dividends.

In which currency does SciVision Biotech pay out the dividend?

The dividends of SciVision Biotech are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von SciVision Biotech

Our stock analysis for SciVision Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SciVision Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.